Syngene International Ltd - 539268 - Yearly Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015
With reference to the captioned subject matter, please find enclosed herewith the Half Yearly Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015, for the year ended on March 31, 2022. Syngene International Ltd - 539268 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Priyadarshini MahapatraDesignation :- Company Secretary and Compliance Officer Syngene International Ltd - 539268 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. Syngene International Ltd - 539268 - Board to consider FY22 results & Final Dividend on April 27, 2022
Syngene International Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on April 27, 2022, inter alia, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended on March 31, 2022 and to consider the recommendation of final dividend, if any, amongst other routine matters.Pursuant to the above, the trading window for dealing in securities of the Company for all Insiders, as defined under the Code of Conduct for Prevention of Insider Trading of the Company, has been closed from April 01, 2022 to April 29, 2022 (both days inclusive) in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.The Company will organize a conference call for analysts and investors on April 28, 2022. The details of the same will be available on the Company's website closer to the scheduled event. Syngene International Ltd - 539268 - Board Meeting Intimation for Intimation Of Board Meeting And Trading Window Closure
Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/04/2022 ,inter alia, to consider and approve Pursuant to regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company will be held on Wednesday, April 27, 2022, inter alia, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended on March 31, 2022 and to consider the recommendation of final dividend, if any, amongst other routine matters. Pursuant to the above, the trading window for dealing in securities of the Company for all Insiders, as defined under the Code of Conduct for Prevention of Insider Trading of the Company, has been closed from April 01, 2022 to April 29, 2022 (both days inclusive) in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
This has reference to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations ,2015, please find attached the details of meetings held/to be held with Analysts/Institutional Investors. Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Credit Rating
Intimation regarding revision in rating under Regulation 30 of SEBI Listing Regulations. Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Credit Rating
Intimation regarding revision in rating under Regulation 30 of SEBI Listing Regulations Syngene International Ltd - 539268 - Change In Directorate
Pursuant to the provisions of regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to notify that Dr Carl Decicco, Director (DIN: 08576667) has informed the Company that he has not been able to appear for the Online Proficiency Test conducted by the Indian Institute of Corporate Affairs before the due date of February 27, 2022 and has accordingly ceased to be an Independent Director of the Company with effect from February 28, 2022. It is further informed that the Board of Directors has approved the appointment of Dr Carl Decicco as Additional Director (Non-executive Non-independent) of the Company with effect from March 01, 2022 till three months from the date of his appointment or the next general meeting of the Company, whichever is earlier. Syngene International Ltd - 539268 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Syngene International Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here